Add Row
Add Element
Glytain Logo
update
Glytain.com
update
Add Element
  • Home
  • Categories
    • Healthcare
    • Innovation
    • Digital
    • Marketing
    • Analysis
    • Insights
    • Trends
    • Empowerment
    • Providers
    • Tech News
    • Extra News
March 28.2025
2 Minutes Read

Exploring Mental Health Outcomes for Native American Adoptees: Insights from Sandy White Hawk

Slide detailing guest speaker on Mental Health Outcomes for Native American Adoptees.

Understanding Mental Health Challenges for Native American Adoptees

In a recent discussion led by Sandy White Hawk, a Lakota advocate and speaker, the complex mental health outcomes for Native American adoptees were highlighted, particularly in the context of historical injustices. Native American adoptees often face unique challenges stemming from their experiences in a system that regularly separates children from their families and cultures. White Hawk emphasized the need for serious research into the mental health impacts of these experiences, citing alarming statistics such as high rates of depression and trauma among adoptees.

In 'Mental Health Outcomes for Native American Adoptees with guest speaker Sandy White Hawk', the conversation revolves around the mental health impacts on adoptees, inspiring a profound exploration of the issues at hand.

The Impact of Adoption on Identity

Adoption, while often framed as a positive solution, can have profound implications on the identity and mental well-being of Native children. White Hawk expressed how adoption can strip away a child's cultural identity, leading to feelings of isolation and disconnection. Many adoptees grapple with their identity in a society that does not recognize the ties they have with their native heritage. This struggle highlights the need for awareness about the importance of cultural belonging for mental health.

Research and Advocacy: A Path Forward

White Hawk's team conducted valuable research involving 336 respondents, discovering deep-rooted issues such as high rates of emotional and physical abuse within adoptive settings. These findings serve as a crucial call to action for social workers and lawmakers. By documenting and sharing the experiences of adoptees, advocates aim to influence policy positively, ensuring that the voices of Native peoples are heard and respected in legal matters concerning child welfare.

Embracing Cultural Healing

A significant aspect of the discussion revolved around the power of cultural healing practices. White Hawk emphasized the role community ceremonies play in supporting adoptees, offering them a sense of belonging and healing. The call for increased visibility and respect for Native cultures in the healing process is paramount, reinforcing the need for integrated therapeutic spaces that honor cultural identities.

A Collective Responsibility

The conversation around mental health outcomes for Native American adoptees isn't just about personal struggles; it highlights a collective responsibility to address historical wrongs and embrace a more informed, kinder approach to adoption and foster care practices. For those involved in social work, education, and advocacy, understanding the nuances of these experiences is crucial in reshaping the conversation.

Sandy White Hawk’s poignant insights remind us of the deep connections between identity, culture, and mental health. As we explore these complex topics, it's essential to engage with and listen to the stories of Native American adoptees to foster greater understanding and healing.

Insights

Write A Comment

*
*
Related Posts All Posts

Amid Rising Gun Violence, Experts Warn About Loss of Prevention Research

Update Gun Violence: A Growing Public Health Crisis In recent weeks, the U.S. has witnessed tragic acts of gun violence, underscoring the need for urgent intervention. The recent shooting incidents, including the murder of activist Charlie Kirk and an attack on students in Colorado, have reignited conversations about how best to tackle this ongoing crisis. Yet, just as these discussions gain momentum, the key organization that once led national efforts to prevent gun violence—the Centers for Disease Control and Prevention (CDC)—has faced sweeping cutbacks. CDC's Crucial Role in Preventing Violence For many years, the CDC was at the forefront of research that illuminated the causes and solutions to firearm-related injuries. However, a significant restructuring has left the agency vulnerable, with the majority of its violence prevention specialists dismissed. Tom Simon, a former director at the CDC’s Division of Violence Prevention, highlighted the tragic irony of these layoffs, noting that this closure follows a gunman’s attack on the CDC headquarters itself. Without these dedicated researchers, public health messaging has become muddled, leading to ineffective strategies and a lack of community support. The Murky Messaging from Leadership The impact of these cuts extends beyond the CDC. Health Secretary Robert F. Kennedy Jr.'s recent comments on school shootings have also cast doubt on the government’s position regarding gun violence. His theories, which link psychiatric medications to violence, lack substantive validation and have further complicated public understanding. Experts like Simon firmly dispute these claims, emphasizing the absence of evidence linking SSRIs to mass shootings. This highlights a pressing need for accurate and science-based discussions as we navigate this crucial public health issue. Opportunities for Grassroots Solutions Despite these challenges, local communities can still play an integral role in addressing gun violence. Grassroots initiatives can foster safety and support through collaborative programs that focus on education, awareness, and outreach. In a time where national programs may be waning, individual efforts can make a substantial difference. As we continue to face rising incidents of gun violence, now more than ever, it’s essential to create informed and proactive strategies moving forward. The loss of expert voices at the CDC is a call to action for communities to band together and drive change at the local level.

Merck's Withdrawal from the UK: A Wake-Up Call for Pharma Investment

Update The Impact of Merck's Decision on the UK Life Sciences Sector In a significant setback for the U.K.’s life sciences ambitions, pharmaceutical giant Merck announced the termination of its research operations and the abandonment of a new research facility in London. This move reflects growing discontent within the pharmaceutical industry over U.K. policies regarding drug pricing and reimbursement practices. Why This Matters: A Strained Relationship The U.K. has made substantial efforts to promote itself as an attractive hub for life sciences, boasting renowned academic institutions and the National Health Service (NHS). However, frustrations are mounting among pharmaceutical companies regarding the government’s approach to new drug pricing and reimbursement. These concerns have been echoed by industry leaders who argue that the current system does not sufficiently incentivize investment in innovative therapies. A Broader Trend in Pharmaceutical Investments Merck's withdrawal is not an isolated incident; it mirrors a broader trend in the industry. Many pharmaceutical companies are reconsidering their investments in the U.K. due to what they perceive as an unsustainable environment for innovation. As these companies prioritize markets that offer more favorable regulatory frameworks, the U.K. risks losing out on groundbreaking research and development. The Future of Drug Development in the UK: Challenges Ahead With Merck pulling out, questions arise regarding the future of drug development in the U.K. Could this lead to a lack of new therapies for patients? What steps can the government take to regain the confidence of pharmaceutical companies? Addressing these challenges will be crucial as the U.K. attempts to reposition itself as a leader in life sciences. This shift calls for proactive dialogue between industry stakeholders and policymakers to create a balance that promotes both innovation and accessibility for patients.

New Narcolepsy Drug Oveporexton: Transforming Patient Lives and the Market

Update Revolutionizing Narcolepsy Treatment: A Game-Changer for PatientsTakeda Pharmaceutical is igniting the narcolepsy market with their groundbreaking drug, oveporexton. This is more than just a new medication; it's a potential catalyst for positive change in the lives of patients suffering from this often-misunderstood disorder. Presenting statistically significant results from their Phase 3 trials at the World Sleep 2025 Congress in Singapore, Takeda's innovative approach aims to treat the root cause of narcolepsy rather than merely alleviate symptoms.Understanding Narcolepsy: More Than Just SleepinessNarcolepsy 1 (NT1) is characterized by excessive daytime sleepiness and sudden muscle weakness known as cataplexy. Current treatments primarily address symptoms, failing to target the underlying deficiency of orexin, a neuropeptide crucial for maintaining wakefulness. Oveporexton differentiates itself as an oral small molecule designed to mimic orexin, binding to orexin receptors to restore necessary activity.Impressive Clinical Trial Outcomes and ImplicationsThe Phase 3 clinical trials showed that patients receiving the lower dose of oveporexton could stay awake 19.3 minutes longer during the maintenance of wakefulness test (MWT), while the high dose extended this to 24.6 minutes. In stark contrast, placebo group results averaged only 4.5 minutes. Such significant improvements not only signify a technical achievement in pharmacology but also offer renewed hope for patients seeking normalcy in their daily lives.Market Impact and Future ProspectsWith Takeda projecting global revenues of $2-3 billion, the potential economic impact is as notable as the clinical one. This drug's approval could shift the landscape of narcolepsy treatment dramatically, addressing an urgent need for solutions that empower patients. As the world waits for regulatory submissions in the U.S. and beyond, the presence of competitors like Alkermes emphasizes the importance of innovation in this vital sector.Conclusion: A Call to Action for Healthcare InnovatorsThe approval of oveporexton could not only reshape the narcolepsy treatment market but also prompt ongoing innovation in related fields. It highlights the critical need for novel therapeutic approaches in chronic conditions often overshadowed in mainstream discourse. Healthcare IT professionals and digital health innovators must remain vigilant and adaptable, ensuring they’re equipped to support emerging treatments that aim to improve patient quality of life and engagement.

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*